Back to Search
JONATHAN SERODY, MD
MD
Hematology & Oncology Physician
NPI: 1790846848IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE
Class of 1986
Research & Publications (20)
Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation.
PMID 10975512·Biol Blood Marrow Transplant·2000
3-trial
T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease.
PMID 11049973·Blood·2000
7-preclinical
T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery.
PMID 10779807·J Immunol·2000
7-preclinical
Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.
PMID 11019843·Bone Marrow Transplant·2000
8-other
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.
PMID 18957685·Blood·2009
7-preclinical
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
PMID 19358012·Leuk Lymphoma·2009
3-trial
Ex vivo inhibition of NF-kappaB signaling in alloreactive T-cells prevents graft-versus-host disease.
PMID 19260829·Am J Transplant·2009
7-preclinical
Intravesicular cidofovir for the management of BK virus-associated cystitis.
PMID 19203733·Biol Blood Marrow Transplant·2009
8-other
Reactivation of cytomegalovirus infection in critically ill immunocompetent patients.
PMID 19033584·JAMA·2008
8-other
The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting.
PMID 18661393·Leuk Lymphoma·2008
6-review
TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.
PMID 18614760·Blood·2008
7-preclinical
C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.
PMID 18535183·Am J Pathol·2008
7-preclinical
CD200 is induced by ERK and is a potential therapeutic target in melanoma.
PMID 18008004·J Clin Invest·2007
8-other
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice.
PMID 17675184·Vaccine·2007
7-preclinical
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD).
PMID 17606761·Blood·2007
7-preclinical
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients.
PMID 17018854·Blood·2007
7-preclinical
Diagnosis and treatment of chronic graft-versus-host disease.
PMID 16412791·Semin Hematol·2006
6-review
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.
PMID 16002422·Blood·2005
7-preclinical
Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies.
PMID 16338625·Biol Blood Marrow Transplant·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 MANNING DR
CHAPEL HILL, NC 27599 - Phone
- (919) 966-4996
Quick Facts
- NPI
- 1790846848
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile